VST is currently looking for investors to further the development of its exciting vascular technology. The first series of investment will aim to conduct the first proof of concept study in vivo and pursue the development of Fibrosil hemodialysis graft, its first targeted application.

​

VST is set up for SEIS and EIS

​

Please contact Stephanie Lesage for further information